NZCR is at the forefront of early phase clinical research. Our focus on quality and innovation has resulted in many exciting medical breakthroughs. These news articles highlight current research projects and innovations at NZCR.
Home / About Us / About NZCR / News
New Zealand Clinical Research (NZCR) is putting put out a call for healthy males in Auckland and Christchurch to be part of two large trials researching potential new treatments for breast cancer.
A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects
NZCR is reducing medical waste and helping the Pacific Islands at the same time
NZCR staff received a lovely surprise this week.
Alvotech receives EU approval for AVT02
NZCR- AKL has opened their new outpatient facility today.
NZCR Supports Covid -19 Vaccination for all New Zealanders.
Lipid and Diabetes Research Group joins the NZCR research family
Drs Christian Schwabe and Dr Chris Wynne are authors of a recent Bevacizumab biosimilar publication.
NZCR CEO receives IQVIA Certificate of Achievement (2020)
Kiwis are being given an opportunity to take part in a trial of a potential new COVID-19 vaccine.
New Zealand is leading the world in a new era of exciting gene research with potential to cure genetic conditions in the future.
